CLINICAL_TRIALS
trial_result
· 2011-05-05
Clinical Trial Update: A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) [Phase 3]
Summary
An update on a Phase 3 trial of belimumab for systemic lupus erythematosus, with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Human Genome Sciences Inc. | Conditions: Systemic Lupus Erythematosus | Phase 3 | Status: COMPLETED | Results posted: 2011-05-05